SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-064673
Filing Date
2014-09-04
Accepted
2014-09-04 10:44:02
Documents
17
Period of Report
2014-09-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-20436_18k.htm 8-K 32892
2 EX-99.1 a14-20436_1ex99d1.htm EX-99.1 27818
3 GRAPHIC g204361mmi001.jpg GRAPHIC 47712
4 GRAPHIC g204361mmi002.gif GRAPHIC 124397
5 GRAPHIC g204361mmi003.gif GRAPHIC 92554
6 GRAPHIC g204361mmi004.gif GRAPHIC 83193
7 GRAPHIC g204361mmi005.jpg GRAPHIC 70813
8 GRAPHIC g204361mmi006.jpg GRAPHIC 63969
9 GRAPHIC g204361mmi007.jpg GRAPHIC 69530
10 GRAPHIC g204361mmi008.jpg GRAPHIC 63338
11 GRAPHIC g204361mmi009.jpg GRAPHIC 60681
12 GRAPHIC g204361mmi010.jpg GRAPHIC 58067
13 GRAPHIC g204361mmi011.jpg GRAPHIC 86350
14 GRAPHIC g204361mmi012.jpg GRAPHIC 66441
15 GRAPHIC g204361mmi013.jpg GRAPHIC 78834
16 GRAPHIC g204361mmi014.jpg GRAPHIC 72207
17 GRAPHIC g204361mmi015.jpg GRAPHIC 45127
  Complete submission text file 0001104659-14-064673.txt   1556496
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8444
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 141082336
SIC: 2834 Pharmaceutical Preparations